Next Article in Journal
Antibiotic Prescribing by Informal Healthcare Providers for Common Illnesses: A Repeated Cross-Sectional Study in Rural India
Next Article in Special Issue
Antimicrobial Activity of Silver Camphorimine Complexes against Candida Strains
Previous Article in Journal
Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship

Bacteriophages as Alternatives to Antibiotics in Clinical Care

Postgraduate Program in Biotechnology, State University of Feira de Santana (UEFS), Av. Transnordestina S/N, Feira de Santana-BA 44036-900, Brazil
Health & Environment Group, Institute of Environmental Sciences and Research, PO Box 29-181, Christchurch 8540, New Zealand
Author to whom correspondence should be addressed.
Received: 2 August 2019 / Revised: 2 September 2019 / Accepted: 3 September 2019 / Published: 4 September 2019
(This article belongs to the Special Issue Feature Paper in Antibiotics for 2019)
Antimicrobial resistance is increasing despite new treatments being employed. With a decrease in the discovery rate of novel antibiotics, this threatens to take humankind back to a “pre-antibiotic era” of clinical care. Bacteriophages (phages) are one of the most promising alternatives to antibiotics for clinical use. Although more than a century of mostly ad-hoc phage therapy has involved substantial clinical experimentation, a lack of both regulatory guidance standards and effective execution of clinical trials has meant that therapy for infectious bacterial diseases has yet to be widely adopted. However, several recent case studies and clinical trials show promise in addressing these concerns. With the antibiotic resistance crisis and urgent search for alternative clinical treatments for bacterial infections, phage therapy may soon fulfill its long-held promise. This review reports on the applications of phage therapy for various infectious diseases, phage pharmacology, immunological responses to phages, legal concerns, and the potential benefits and disadvantages of this novel treatment. View Full-Text
Keywords: bacteriophages; clinical trials; antibiotic resistance; infectious disease; phage therapy bacteriophages; clinical trials; antibiotic resistance; infectious disease; phage therapy
Show Figures

Figure 1

MDPI and ACS Style

Romero-Calle, D.; Guimarães Benevides, R.; Góes-Neto, A.; Billington, C. Bacteriophages as Alternatives to Antibiotics in Clinical Care. Antibiotics 2019, 8, 138.

AMA Style

Romero-Calle D, Guimarães Benevides R, Góes-Neto A, Billington C. Bacteriophages as Alternatives to Antibiotics in Clinical Care. Antibiotics. 2019; 8(3):138.

Chicago/Turabian Style

Romero-Calle, Danitza, Raquel Guimarães Benevides, Aristóteles Góes-Neto, and Craig Billington. 2019. "Bacteriophages as Alternatives to Antibiotics in Clinical Care" Antibiotics 8, no. 3: 138.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop